Alpha-1 Foundation

OrganisationROR

Trials

  • NCT03008915

    Collaborator, Phase 2, Completed, 15 people, 4 Jan 2017

Named in competing interests

Sources: pubmed.ncbi.nlm.nih.gov, doi.org